PRTN3 and rheumatoid arthritis: In this study including four groups of ACPA positive individuals with different characteristics, we found higher levels of inflammatory markers (CRP, IL-6 and TNFR1) and endothelial cell activation marker (VEGF) in the RA risk patients compared to individuals with or without joint complaints.